GGrantIndex
← Leaderboards

Robert C Bollinger

Johns Hopkins University

$22,864,089
Attributed
$22,864,089
Total exposure
8
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.7M · FY200517
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$22,864,089 · 8

By mechanism

U01$15,254,660 · 3
R01$6,508,100 · 2
D43$1,019,371 · 1
R03$81,958 · 1
M01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “India

Research focus

IndiaHiv InfectionsClinical ResearchHuman SubjectAids Education /PreventionHuman Therapy EvaluationAids TherapyClinical TrialsHuman Immunodeficiency Virus 1AidsBaseDrug ResistanceLeadershipSuccessResearch InfrastructureAcquired Immunodeficiency SyndromeProgramsResearch InstituteGrantDesignEpidemiologyMedical Outreach /Case FindingCytotoxic T LymphocyteClinical Trial Phase I

Grant awards (31)

HIV-TB Fogarty Research Training Program$255,537
D43 · FY2017 · TW · contact PI
HIV-TB Fogarty Research Training Program$1
D43 · FY2016 · TW · contact PI
HIV-TB Fogarty Research Training Program$268,881
D43 · FY2015 · TW · contact PI
HIV-TB Fogarty Research Training Program$267,094
D43 · FY2014 · TW · contact PI
HIV-TB Fogarty Research Training Program$227,858
D43 · FY2013 · TW · contact PI
Byramee Jeejeebhoy Medical College (BJMC), Pune, India: Clinical Trials Unit$1,001,920
U01 · FY2009 · AI · contact PI
Byramee Jeejeebhoy Medical College (BJMC), Pune, India: Clinical Trials Unit$1,164,387
U01 · FY2008 · AI · contact PI
Prevention of Maternal-to-Infant HIV Transmission/India$49,623
U01 · FY2008 · AI · contact PI
Prevention of Maternal-to-Infant HIV Transmission/India$466,852
U01 · FY2007 · AI · contact PI
Byramee Jeejeebhoy Medical College (BJMC), Pune, India: Clinical Trials Unit$100,000
U01 · FY2007 · AI · contact PI
Prevention of Maternal-to-Infant HIV Transmission/India$1,061,322
U01 · FY2006 · AI · contact PI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$489,695
U01 · FY2006 · AI · contact PI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$2,053,338
U01 · FY2005 · AI
Prevention of Maternal-to-Infant HIV Transmission /India$1,235,754
U01 · FY2005 · AI
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$406,466
R01 · FY2005 · AI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$2,020,124
U01 · FY2004 · AI
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$401,562
R01 · FY2004 · AI
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$336,000
R01 · FY2004 · AI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$2,102,817
U01 · FY2003 · AI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$1,923,636
U01 · FY2002 · AI
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$1,823,377
R01 · FY2002 · AI
RELIABILITY/REPRODUCIBILITY OF MEASUREMENT OF CTL ACTIVITY IN HIV$0
M01 · FY2002 · RR
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$1,770,269
R01 · FY2001 · AI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$835,191
U01 · FY2001 · AI
PATHOGENESIS OF ACUTE PRIMARY HIV INFECTION IN INDIA$317,694
R01 · FY2001 · AI
RELIABILITY/REPRODUCIBILITY OF MEASUREMENT OF CTL ACTIVITY IN HIV$0
M01 · FY2001 · RR
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIA$1,058,587
R01 · FY2000 · AI
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA$750,001
U01 · FY2000 · AI
PATHOGENESIS OF ACUTE PRIMARY HIV INFECTION IN INDIA$394,145
R01 · FY2000 · AI
HIV SPECIFIC CTL ACTIVITY IN CONCORDANT/DISCORDANT PAIRS$81,958
R03 · FY2000 · AI
RELIABILITY/REPRODUCIBILITY OF MEASUREMENT OF CTL ACTIVITY IN HIV$0
M01 · FY2000 · RR